Results 1 to 10 of about 400,796 (284)

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder

Journal of Urology
The purpose of this guideline is to provide evidence‐based guidance to clinicians of all specialties on the evaluation, management, and treatment of idiopathic overactive bladder (OAB).
Ekene Enemchukwu, Eric Rovner
exaly   +2 more sources

Prevalence and burden of overactive bladder in the United States

World Journal of Urology, 2003
Geoffrey Cundiff, A R Herzog, W F Stewart   +2 more
exaly   +2 more sources

European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.

European Urology, 2022
CONTEXT Female lower urinary tract symptoms (LUTS) are a common presentation in urological practice. Thus far, only a limited number of female LUTS conditions have been included in the European Association of Urology (EAU) guidelines compendium.
A. Nambiar, S. Arlandis, K. Bø, H. Cobussen-Boekhorst, E. Costantini, Monica de Heide, F. Farag, J. Groen, M. Karavitakis, M. C. Lapitan, M. Manso, S. Arteaga, A. N. Riogh, E. O'Connor, M. I. Omar, B. Peyronnet, V. Phé, V. Sakalis, N. Sihra, L. Tzelves, M. van Poelgeest-Pomfret, Tine W L van den Bos, H. van der Vaart, C. Harding   +23 more
semanticscholar   +1 more source

Pathophysiological Mechanisms Involved in Overactive Bladder/Detrusor Overactivity

Current Bladder Dysfunction Reports, 2023
Purpose of Review To examine the latest published findings on the pathophysiological mechanisms involved in the development of overactive bladder (OAB) and detrusor overactivity (DO), and to identify common pathways linked to the risk factors associated ...
R. Chess-Williams, D. Sellers
semanticscholar   +1 more source

Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies

Biomedicines, 2022
Metabolic syndrome (MetS) is defined by a group of cardiovascular risk factors, including impaired glucose tolerance, central obesity, hypertension, and dyslipidemia.
L. Hsu, Ju-Chuan Hu, P. Chen, Wei-Chia Lee, Y. Chuang   +4 more
semanticscholar   +1 more source

Relationship between marijuana use and Overactive Bladder (OAB): a cross-sectional research of National Health and Nutrition Examination Survey (NHANES) 2005 to 2018.

American Journal of Medicine, 2022
BACKGROUND Current research is starting to focus on the medical value of marijuana and the possible health problems it can cause. Previous studies have shown that marijuana can relieve lower urinary tract symptoms, which can pose a significant public ...
Shenhao Zhu, Zhongyuan Wang, Zhijun Tao, Shangqian Wang, Zengjun Wang   +4 more
semanticscholar   +1 more source

Barriers and facilitators to overactive bladder therapy adherence

Neurourology and Urodynamics, 2022
To provide an overview of the barriers and facilitators to overactive bladder (OAB) therapy initiation and adherence.
E. Enemchukwu, L. Subak, A. Markland
semanticscholar   +1 more source

Associations Between Unmet Social Needs and Overactive Bladder

Journal of Urology, 2022
Purpose: There is growing interest in how social determinants of health may explain relationships between social conditions and health. Overactive bladder is common in the United States, posing a significant public health burden.
E. Sebesta, Stephanie Gleicher, M. Kaufman, R. Dmochowski, W. Reynolds   +4 more
semanticscholar   +1 more source

Overactive bladder: A review and update.

Experimental and Therapeutic Medicine, 2021
Overactive bladder syndrome is a chronic, disabling condition with physical, psychological and social consequences that significantly affects the quality of life of millions of patients worldwide.
I. Scârneciu, S. Lupu, O. Bratu, A. Teodorescu, L. Maxim, A. Brînză, A. Laculiceanu, R. Rotaru, A. Lupu, C. Scârneciu   +9 more
semanticscholar   +1 more source

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder

IJU Case Reports, 2022
Introduction We report a case of deterioration of bladder compliance after botulinum toxin type A injection and discontinuation of medication for overactive bladder.
Naoki Wada, Mayumi Ishikawa, Masaya Nagabuchi, Shogo Makino, Kotona Miyauchi, Noriyuki Abe, Hidehiro Kakizaki   +6 more
doaj   +1 more source